home / stock / cere / cere articles

CERE Articles, Ceres Inc. - From 12/07/23

Stock Information
Company Name: Ceres Inc.
Stock Symbol: CERE
Market: NASDAQ
Website: cerevel.com
Menu
CERE CERE Quote CERE Short CERE News CERE Articles CERE Message Board
Get CERE Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings. Methode Electronics ...
Why Cerevel Therapeutics Stock Is Higher | Benzinga

Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) shares are trading higher Thursday after AbbVie, Inc. (NYSE: ABBV) announced it will acquire the...

Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining more than 100 points on Thursday. Shares of Verint Systems Inc. (NASDAQ: VRNT) ...

Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquir...
Datadog To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Why Cerevel Therapeutics Holdings Is Moving After-Hours | Benzinga

Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading higher in Wednesday's after-hours session after AbbVie Inc. (NYS...

NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points on Tuesday. Shares of NIO Inc. (NYSE: NIO) moved higher duri...
Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson's Disease | Benzinga

Event will focus on tavapadon, a D1/D5 partial agonist in Phase 3 development for the treatment of Parkinson's disease Live webcast scheduled...

Cerevel Therapeutics to Present at Upcoming Investor Conferences | Benzinga

CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the b...

Cerevel Therapeutics Hldg Insider Trades Send a Signal | Benzinga

BAIN CAPITAL INVESTORS LLC, 10% Owner at Cerevel Therapeutics Hldg (NASDAQ:CERE), reported a large insider buy on October 18, according to a new SE...
Previous 10 Next 10